GlassScriptPhysician profile
Joseph Grady Elliott
NPI 1285774166
$1,804.32
in general payments reported to CMS, 2019-2025
14 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.94 · 2020: $75.32 · 2021: $230 · 2022: $130 · 2023: $400 · 2024: $546 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,270.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $587.33 | 2020-2025 | Clareon, Precision 7, Acrysof Iq Panoptix Uv Iol |
| Coopervision INC. | $368.33 | 2019-2024 | Myday Contact Lens, Misight Contact Lens |
| Amgen INC. | $191.63 | 2024-2025 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $120.33 | 2019-2021 | |
| Oyster Point Pharma, INC. | $103.75 | 2023 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $98.92 | 2024 | Acthar |
| Carl Zeiss Meditec USA, INC. | $98.42 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $72.15 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $57.48 | 2019 | |
| Sun Pharmaceutical Industries INC. | $27.74 | 2025 | |
| Abbvie INC. | $21.77 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $19.83 | 2023 | Acuvue |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.